Although mutation or inactivation of the Von Hippel-Lindau (VHL) tumor-suppressor gene is considered the hallmark of ccRCC, the second most mutated gene after VHL is PBRM1 [6,7,8,9,10]. Here, VHL is linked to neoplasm.